ArticleJournal of immunotherapy and precision oncology2026

Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced

Muhammad Rizwan Khawaja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.